Ranjitkar Manandhar, Nora, Gyan Krishna Kayastha, and Paras Kumar Acharya. “Dasatinib Tyrosine Kinase Inhibitor As Second and Third Line Therapy in Chronic Myeloid Leukemia: Outcome of a Nepalese Study”. Journal of Patan Academy of Health Sciences 5, no. 1 (July 25, 2018): 47–56. Accessed October 25, 2024. https://jpahs.edu.np/index.php/jpahs/article/view/97.